share_log

Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH

Benzinga ·  Feb 28 20:12
Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment